The new advances in biotechnology DNA, rNA, fermentation, the Human Genome and cloning are linked to the solid science of the pharmaceutical industry and so are their regulatory roots.
Magid-Haffner Associates, Inc. also has its roots deep within the science and regulatory compliance of the pharmaceutical industry, but also has the knowledge and expertise to provide cutting edge regulatory guidance to the established biotechnology firms, as well as to the new start-up biotechnology firms that will become the leaders in the future.